169 related articles for article (PubMed ID: 38688649)
1. Correlation Between Low Cytoplasmic Expression of XBP1 and the Likelihood of Surviving Hepatocellular Carcinoma.
Hsu HT; Lin YM; Hsing MT; Yeh KT; Lu JW; Yang SF
In Vivo; 2024; 38(3):1316-1324. PubMed ID: 38688649
[TBL] [Abstract][Full Text] [Related]
2. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
[TBL] [Abstract][Full Text] [Related]
3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
5. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
[TBL] [Abstract][Full Text] [Related]
6. The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients.
Chen YL; Lin PY; Ming YZ; Huang WC; Chen RF; Chen PM; Chu PY
BMC Cancer; 2017 Jul; 17(1):474. PubMed ID: 28687090
[TBL] [Abstract][Full Text] [Related]
7. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.
Liu H; Wu Q; Liu Y; Liu W; Zhang W; Pan D; Xu J
Jpn J Clin Oncol; 2015 Sep; 45(9):844-53. PubMed ID: 26056329
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.
Chen J; Liu J; Jin R; Shen J; Liang Y; Ma R; Lin H; Liang X; Yu H; Cai X
PLoS One; 2014; 9(11):e111885. PubMed ID: 25401330
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
[TBL] [Abstract][Full Text] [Related]
11. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-specific protease 11 serves as a marker of poor prognosis and promotes metastasis in hepatocellular carcinoma.
Zhang S; Xie C; Li H; Zhang K; Li J; Wang X; Yin Z
Lab Invest; 2018 Jul; 98(7):883-894. PubMed ID: 29545598
[TBL] [Abstract][Full Text] [Related]
14. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.
Pan JJ; Ge YS; Xu GL; Jia WD; Liu WF; Li JS; Liu WB
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1043-54. PubMed ID: 23525579
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
16. High-level expression of HOXB13 is closely associated with tumor angiogenesis and poor prognosis of hepatocellular carcinoma.
Zhu JY; Sun QK; Wang W; Jia WD
Int J Clin Exp Pathol; 2014; 7(6):2925-33. PubMed ID: 25031711
[TBL] [Abstract][Full Text] [Related]
17. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Ahn S; Hyeon J; Park CK
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
[TBL] [Abstract][Full Text] [Related]
19. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
20. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
